Medical Xpress·3 min read·hard
New heart disease mechanism revealed: Next-generation targeted therapy shows benefit across mutation types
C
Centro Nacional de Investigaciones Cardiovasculares
✦AI Summary
A study led by the CNIC has identified a new molecular mechanism in hypertrophic cardiomyopathy and confirmed that the drug mavacamten is effective across various genetic mutations. This provides a more targeted approach to treating the most common inherited heart disease.
Why it matters
Advancements in treating hypertrophic cardiomyopathy are vital for reducing the risk of sudden cardiac death in young people and athletes.
by Centro Nacional de Investigaciones Cardiovasculares
healthscience
Political Bias
Center
LeftLean LCenterLean RRight
Confidence: 95%
The article summarizes medical research findings objectively.
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in